P3 Health Partners Gelecekteki Büyüme
Future kriter kontrolleri 1/6
P3 Health Partners is forecast to grow earnings and revenue by 88.7% and 15.2% per annum respectively while EPS is expected to grow by 79% per annum.
Anahtar bilgiler
88.7%
Kazanç büyüme oranı
79.0%
EPS büyüme oranı
| Healthcare kazanç büyümesi | 20.1% |
| Gelir büyüme oranı | 15.2% |
| Gelecekteki özkaynak getirisi | n/a |
| Analist kapsamı | Low |
| Son güncelleme | 04 Sep 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Health Check: How Prudently Does P3 Health Partners (NASDAQ:PIII) Use Debt?
Aug 26
P3 Health Partners: Moving In The Right Direction In 2024
Jun 07P3 Health Partners GAAP EPS of -$3.73, revenue of $269.45M
Oct 20P3 Health gets Nasdaq notice for delisting, plans appeal
Oct 05P3 Health expands Nevada footprint with acquisition of Pahrump cardiology practice
Aug 29P3 Health Partners receives Nasdaq notice for non-compliance
Aug 19Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2026 | 2,104 | 15 | N/A | N/A | 1 |
| 12/31/2025 | 1,750 | -19 | 61 | 66 | 4 |
| 12/31/2024 | 1,521 | -39 | -6 | -1 | 4 |
| 6/30/2024 | 1,403 | -69 | -54 | -54 | N/A |
| 3/31/2024 | 1,353 | -67 | -74 | -72 | N/A |
| 12/31/2023 | 1,266 | -58 | -78 | -76 | N/A |
| 9/30/2023 | 1,178 | -126 | -94 | -92 | N/A |
| 6/30/2023 | 1,138 | -124 | -108 | -105 | N/A |
| 3/31/2023 | 1,078 | -269 | -124 | -122 | N/A |
| 12/31/2022 | 1,049 | -270 | -128 | -126 | N/A |
| 9/30/2022 | 977 | -100 | -123 | -121 | N/A |
| 6/30/2022 | 884 | -121 | -108 | -105 | N/A |
| 3/31/2022 | 760 | 4 | -85 | -81 | N/A |
| 12/31/2021 | 637 | -10 | -70 | -66 | N/A |
| 9/30/2021 | 582 | -90 | -61 | -58 | N/A |
| 6/30/2021 | 555 | -74 | -57 | -54 | N/A |
| 3/31/2021 | 527 | -49 | -43 | -40 | N/A |
| 12/31/2020 | 491 | -31 | -28 | -25 | N/A |
| 12/31/2019 | 145 | -42 | -30 | -28 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: PIII is forecast to remain unprofitable over the next 3 years.
Kazançlar ve Piyasa: PIII is forecast to remain unprofitable over the next 3 years.
Yüksek Büyüme Kazançları: PIII is forecast to remain unprofitable over the next 3 years.
Gelir ve Pazar: PIII's revenue (15.2% per year) is forecast to grow faster than the US market (8.9% per year).
Yüksek Büyüme Geliri: PIII's revenue (15.2% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if PIII's Return on Equity is forecast to be high in 3 years time